Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-17-005912
Filing Date
2017-05-26
Accepted
2017-05-26 16:15:22
Documents
1
Period of Report
2017-05-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K f8k051217a1_actiniumpharm.htm 8-K/A 16671
  Complete submission text file 0001213900-17-005912.txt   17935
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36374 | Film No.: 17874137
SIC: 2834 Pharmaceutical Preparations